Price Chart

Profile

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
URL http://www.paxmedica.com
Investor Relations URL https://www.paxmedica.com/investors
HQ State/Province New York
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release N/A
Last Earnings Release Mar. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
URL http://www.paxmedica.com
Investor Relations URL https://www.paxmedica.com/investors
HQ State/Province New York
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release N/A
Last Earnings Release Mar. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A